Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:2076-2079

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, J.
Right arrow Articles by Schroth, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, J.
Right arrow Articles by Schroth, G.

(Stroke. 1998;29:2076-2079.)
© 1998 American Heart Association, Inc.


Original Contributions

Selective Intra-Arterial Fibrinolysis of Acute Central Retinal Artery Occlusion

Johannes Weber, MD; Luca Remonda, MD; Heinrich P. Mattle, MD; Ursula Koerner, MD; Ralf W. Baumgartner, MD; Matthias Sturzenegger, MD; Christoph Ozdoba, MD; Fritz Koerner, MD; Gerhard Schroth, MD

From the Departments of Neuroradiology (J.W., L.R., C.O., G.S.), Neurology (J.W., H.P.M., R.W.B., M.S.), and Ophthalmology (U.K., F.K.), Inselspital, University of Bern, Bern, Switzerland.

Correspondence to G. Schroth, MD, University of Bern, Department of Neuroradiology, Inselspital, 3010 Bern, Switzerland. E-mail gerhard.schroth{at}insel.ch

Background and Purpose—Occlusion of the central retinal artery (CRAO) causes a sudden decrease of monocular vision. Because early restoration of blood flow may improve outcome, we attempted to treat CRAO with selective intra-arterial fibrinolysis.

Methods—Intra-arterial fibrinolysis was performed within 6 hours after symptom onset in 17 patients with thromboembolic CRAO. Symptoms were painless, acute and severe decrease of vision. Urokinase (100 000 to 900 000 IU) was given through a microcatheter into the ophthalmic artery over 10 to 90 minutes. For comparison, the history and visual outcome of 15 control patients who did not receive fibrinolytics were evaluated. In both groups some of the patients underwent paracentesis and/or received carboanhydrase inhibitors.

Results—Patients who underwent fibrinolysis fared better than control patients (P=0.01). Three patients (17.6%) recovered completely after fibrinolysis and regained visual acuity of 20/20 (n=2) to 25/20 (n=1). Two additional patients (11.8%) showed a marked improvement to a visual acuity of 20/30. In 6 patients (35.3%) vision improved slightly. They were able to count fingers, detect hand movements, or perceive light. In 6 patients (35.3%), fibrinolytic treatment was without effect. Among control patients, 1 patient (6.7%) showed partial, 4 patients (26.7%) minimal, and 10 (66.7%) no improvement of vision.

Conclusions—A complete or marked improvement of visual acuity was achieved in one third of intra-arterial fibrinolysis patients but in none of the control patients. Intra-arterial fibrinolysis seems to have the potential to "lighten" the spontaneously poor outcome of CRAO.


Key Words: fibrinolysis • retinal artery occlusion • thrombolysis




This article has been cited by other articles:


Home page
StrokeHome page
E. M. Aldrich, A. W. Lee, C. S. Chen, R. F. Gottesman, M. N. Bahouth, P. Gailloud, K. Murphy, R. Wityk, and N. R. Miller
Local Intraarterial Fibrinolysis Administered in Aliquots for the Treatment of Central Retinal Artery Occlusion: The Johns Hopkins Hospital Experience
Stroke, June 1, 2008; 39(6): 1746 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
S. S. Hayreh
Intra-arterial thrombolysis for central retinal artery occlusion
Br J Ophthalmol, May 1, 2008; 92(5): 585 - 587.
[Full Text] [PDF]


Home page
Br J OphthalmolHome page
J Noble, N Weizblit, M O Baerlocher, and K T Eng
Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review
Br J Ophthalmol, May 1, 2008; 92(5): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
O. K. Schwenn, E. G. Wustenberg, M. A. Konerding, and L.-O. Hattenbach
Experimental Percutaneous Cannulation of the Supraorbital Arteries: Implication for Future Therapy
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1557 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Arnold, U Koerner, L Remonda, K Nedeltchev, H P Mattle, G Schroth, M Sturzenegger, J Weber, and F Koerner
Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 196 - 199.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D. P. Schmidt, J. Schulte-Monting, and M. Schumacher
Prognosis of Central Retinal Artery Occlusion: Local Intraarterial Fibrinolysis versus Conservative Treatment
AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1301 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
J. C. Kattah, D. Z. Wang, and C. Reddy
Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis in Treatment of Central Retinal Artery Occlusion
Arch Ophthalmol, September 1, 2002; 120(9): 1234 - 1236.
[Full Text] [PDF]


Home page
IOVSHome page
L. Daugeliene, M. Niwa, A. Hara, H. Matsuno, T. Yamamoto, Y. Kitazawa, and T. Uematsu
Transient Ischemic Injury in the Rat Retina Caused by Thrombotic Occlusion-Thrombolytic Reperfusion
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2743 - 2747.
[Abstract] [Full Text]


Home page
Br J OphthalmolHome page
S Beatty and K G A. Eong
Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data
Br J Ophthalmol, August 1, 2000; 84(8): 914 - 916.
[Abstract] [Full Text]